Literature DB >> 3886430

Role of the brain-stem reticular formation in tonic-clonic seizures: lesion and pharmacological studies.

R A Browning.   

Abstract

Bilateral lesions of the pontine tegmentum involving the superior cerebellar peduncles and the nucleus reticularis pontis oralis have been shown to attenuate the tonic components of maximal seizures induced by electroshock, sound stimulation (audiogenic), or pentylenetetrazol, although having no effect on clonus in three separate seizure models. The pontine tegmental lesion also abolishes the clonus of minimal audiogenic seizures that have a motor pattern different from that of other clonic models, and are believed to originate in the brain stem. The preponderant suppression of tonus by the pontine tegmental lesion as well as the inhibition of clonus in audiogenic seizures is strikingly similar to the effects of phenytoin in these same seizure models. The findings presented are consistent with the hypothesis that the pontine reticular formation (RF) plays a key role in the generation and/or expression of tonic convulsions. Additional findings are presented that suggest that serotonin may attenuate the tonic components of maximal electroshock seizures by an action on the brain stem. Thus, it seems likely that pontine tegmental lesions as well as antiepileptic drugs and neurotransmitters with preferential effects on tonic seizures act on a common neural substrate that appears to include the brain-stem RF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886430

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  24 in total

1.  Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli.

Authors:  P Szot; D Weinshenker; S S White; C A Robbins; N C Rust; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 2.  The role of the brain stem in generalized epileptic seizures.

Authors:  C L Faingold
Journal:  Metab Brain Dis       Date:  1987-06       Impact factor: 3.584

3.  Rats with different thresholds to clonic convulsions induced by DMCM differ in the binding of [3H]-MK-801 and [3H]-ouabain in the membranes of brain regions.

Authors:  Marcos Brandão Contó; José Gilberto Barbosa de Carvalho; Marco Antonio Campana Venditti
Journal:  Neurochem Res       Date:  2012-03-01       Impact factor: 3.996

4.  Regional neural activity within the substantia nigra during peri-ictal flurothyl generalized seizure stages.

Authors:  Jana Velísková; Alexandra M Miller; Magda L Nunes; Lucy L Brown
Journal:  Neurobiol Dis       Date:  2005-06-13       Impact factor: 5.996

5.  Excitation, but not inhibition, of the fastigial nucleus provides powerful control over temporal lobe seizures.

Authors:  Martha L Streng; Esther Krook-Magnuson
Journal:  J Physiol       Date:  2019-12-09       Impact factor: 5.182

6.  Pentylenetetrazol-induced seizures in rats: an ontogenetic study.

Authors:  L Velisek; H Kubova; M Pohl; L Stankova; P Mares; R Schickerova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

7.  Audiogenic seizures in Wistar rats before and after repeated auditory stimuli: clinical, pharmacological, and electroencephalographic studies.

Authors:  M Kiesmann; C Marescaux; M Vergnes; G Micheletti; A Depaulis; J M Warter
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

8.  Traumatic brain injury during development reduces minimal clonic seizure thresholds at maturity.

Authors:  Kimberly D Statler; Seth Swank; Tracy Abildskov; Erin D Bigler; H Steve White
Journal:  Epilepsy Res       Date:  2008-05-19       Impact factor: 3.045

9.  Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.

Authors:  Malika El Yacoubi; Catherine Ledent; Marc Parmentier; Jean Costentin; Jean-Marie Vaugeois
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-06-02       Impact factor: 3.000

10.  Convulsant action of a benzodiazepine receptor agonist/inverse agonist Ro 19-4603 in developing rats.

Authors:  H Kubová; P Mares
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.